Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group. - Wikidata - awgldk - TriplyDB

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

http://www.wikidata.org/entity/Q37466737

about

Esophageal testing: What we have so far Comparison of oesophageal function tests between Chinese non-erosive reflux disease and reflux hypersensitivity patients Increase of transient lower esophageal sphincter relaxation associated with cascade stomach.Cytoprotective effects of hydrogen sulfide in novel rat models of non-erosive esophagitis.Non-erosive and uncomplicated erosive reflux diseases: Difference in physiopathological and symptom pattern.Improvement in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey Esomeprazole regimens for reflux symptoms in Chinese patients with chronic gastritis A randomized open-label trial of on-demand rabeprazole vs ranitidine for patients with non-erosive reflux disease.Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls.Current and emerging therapies for the management of functional gastrointestinal disorders.Minimal endoscopic changes in non-erosive reflux disease.Current advances in the diagnosis and treatment of nonerosive reflux disease.Efficacy and Safety of a Natural Remedy for the Treatment of Gastroesophageal Reflux: A Double-Blinded Randomized-Controlled Study.Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.Endoscopy in the diagnosis and management of motility disorders.Gastroesophageal reflux disease and airway hyperresponsiveness: concomitance beyond the realm of chance?Gastroesophageal reflux disease--from reflux episodes to mucosal inflammation.Management of noncardiac chest pain in women.Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!Overlap of functional dyspepsia and GERD--diagnostic and treatment implications.NERD: an umbrella term including heterogeneous subpopulations.Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.Between GERD and NERD: the relevance of weakly acidic reflux.The natural history of gastro-esophageal reflux disease: a comprehensive review.Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?Outcomes in patients with nonerosive reflux disease treated with a proton pump inhibitor and alginic acid ± glycyrrhetinic acid and anthocyanosides.PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis.Proteinase-activated receptor-2 in the pathogenesis of gastroesophageal reflux disease.A weakly acidic solution containing deoxycholic acid induces esophageal epithelial apoptosis and impairs integrity in an in vivo perfusion rabbit model.Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression Changes in the esophageal mucosa of patients with non erosive reflux disease: How far have we gone?Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease?Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study.Effect of nortriptyline on brain responses to painful esophageal acid infusion in patients with non-erosive reflux disease.More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.Autofluorescence imaging endoscopy for predicting acid reflux in patients with gastroesophageal reflux disease.Juice Test for Identification of Nonerosive Reflux Disease in Heartburn Patients.Study on the Therapeutic Effects of Drug and Cognitive-Behavioral Therapy on Non-Erosive Reflux Disease Patients With Emotional Disorders.

P2860

Q26766661-91D05745-8A32-4D3B-9F51-E4C0565C428E Q33721946-98C9A8DB-3DEF-40AE-9515-C9E0D516472E Q33751127-714A797B-EBD4-4E17-9F76-874DEA27CA89 Q34380226-EC3AC369-6736-4146-B07C-08B331E80FEC Q35172943-774C42C1-476C-4560-8D9D-9FC79348E4B0 Q35268223-E681B665-83DF-423F-9AE6-8960C04DFD02 Q35716289-65AA4119-C437-4D3A-9E22-0A2B61E5A204 Q35963755-82258483-D729-4D50-BFF6-ABD84A4A32E4 Q36230154-2FD84871-2BCF-4C1E-9229-1A8CCB3D72CB Q36443725-DA219291-035F-4FE8-9F4D-E5795757D334 Q36538275-801F99C4-51A9-4CF3-8307-9594623AAD75 Q37051858-D8525DCF-6357-498C-8658-2A2FABD7F5CE Q37366593-3BD9ACF6-EBD0-4CFD-879C-742D24F096A0 Q37696562-F3FA439A-5312-41D5-9ECF-A3DAA256D443 Q37834418-E89185B4-C51A-481A-A569-59EA4C6B0C40 Q37951380-0C6BC537-B179-4C6A-8D67-0D6E349A746A Q37959240-07A1E242-F61A-4F94-9362-3F831A31A48F Q37989175-4D247AA4-ACD1-4360-93BD-1B4E4369F77B Q38025449-BBB128D7-6F51-48F2-9AC7-DB2727BBC302 Q38072281-2874DBDF-8356-4AE8-A21D-AB91FF6D3927 Q38092939-13CF77AB-2B68-4E9D-A63F-150588BB3BE2 Q38154876-9AB8E160-B69A-4172-ADF2-F486453254FC Q38912494-9E7E95F1-72A2-4A99-B955-C11F01A2B217 Q39013080-EAF69BCD-5D8A-42E5-8849-3E939E62EA72 Q39221366-BB3FCE40-46AE-4263-901A-AA5CD51CA608 Q39229328-F5AE150A-D440-4453-ACBE-A46B90267634 Q39252347-AF749F3C-EEAC-4330-A4EB-85850ECF2852 Q39686970-50BB0B8B-BE93-49B0-B91E-FBEB8FE4CE24 Q39952430-89B5ACB5-C9EE-4C7F-A4E9-757D8BBC72C1 Q41103071-4D3DCE44-3C34-49C5-A675-AFEF93A51503 Q42371575-AE0ACCAE-7617-4224-833F-71F012E27C65 Q42544835-37644F8F-40B8-4713-BB5F-54B541DA8746 Q42923401-CEC6A02E-28B6-4F60-A958-9363797A8DF8 Q48526596-2887B76E-3BCB-4DD2-BAD0-6EAC8F580410 Q48894383-D92E30C6-B97E-4694-AB8B-F5CE39B9B5E1 Q50670792-83703784-1814-4FB1-A593-D6AFBD951261 Q51039626-FE1C813E-FEE3-4916-B3BE-28150A0D9186 Q53644444-410200A0-50E2-4ECF-88E3-0054EDF05C6B Q55087650-512585B4-A7A4-41A6-A2EF-56A20C54BAB9 Q55114364-1C9C4B5F-DB00-4249-82BC-9D4268BCB51B

P2860

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

http://www.wikidata.org/entity/Q37466737

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

@en

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

@nl

type

label

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

@en

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

@nl

prefLabel

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

@en

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

@nl

P1433

Q37466737-983A1AD2-93AB-45B1-B0CD-C8C93E1A236B

P1476

Q37466737-95B36E1D-8DA1-445B-B24A-79D06380CB83

P2093

Q37466737-3B46BC93-19C8-48E8-974B-E2D405B335E8

Q37466737-46041371-C2C3-4F9E-8D08-994848E6762F

Q37466737-5EA069F8-958B-47A7-9E27-28267741F6CC

Q37466737-82862DC3-8517-4ED1-8442-55474C47DBD2

Q37466737-86BF7B97-62CF-4B4E-93F6-785E8C683206

Q37466737-8E106503-CE00-4C04-A8B4-1C1A89EEEE47

Q37466737-C86BA91F-97C7-4959-93F8-D520AE904A69

Q37466737-EF372906-0346-47E1-A248-B20DFF1FD729

Q37466737-FB4D1248-3640-44B9-A98D-9AD697E11288

Q37466737-FC30EC77-DB4A-41B0-9C7F-996393AA3EFF

P2860

Q37466737-042687CB-94D4-41B6-A42A-8EBFF2C5C56E

Q37466737-081DE706-EDE6-401F-BAA3-EAFBE953ED57

Q37466737-0DBC8D51-7AAB-407C-BD49-3868EFB4D594

Q37466737-10C41EFC-926E-404D-BAD7-5C0C3B3E14C6

Q37466737-1393186A-046B-4EE6-AF64-302F927F71DE

Q37466737-1620904C-E806-44E8-9088-C3CE763EA6C9

Q37466737-1DF55AD7-D887-4928-8962-A83163AFC12E

Q37466737-1F54A208-830F-4309-AF18-CC5CBF293FD6

Q37466737-1FE1E215-9AF5-4B79-B1A9-0F648318FED2

Q37466737-20C9B0F1-7DBB-4B4A-95F0-DB61755DC348

P304

Q37466737-3A34EBB3-4224-41BF-8FD8-A604A4DD2389

P31

Q37466737-58066978-35B0-49FD-ADF3-04EA8671AA92

P356

Q37466737-4FA5E862-5407-4711-B272-06EDA0DE6D76

P433

Q37466737-58C5003A-EDED-4549-A96D-8C90E905D55F

P478

Q37466737-63FE812A-067C-4EF8-8B2C-FE0282F6985C

P50

Q37466737-66C71A0A-50BD-466E-8E3F-FD844BF5053E

P577

Q37466737-FC51ECDB-76F5-4829-95BC-DD061D45A9C7

P5875

Q37466737-FA0EF8AF-EFF0-4368-9BE2-D5A4CC6DF76B

P698

Q37466737-EC712385-FD4C-4F82-B132-CD4DED7C2E65

P921

Q37466737-e630435f-8dcf-40cb-8a75-b6030b81007b

P932

Q37466737-65CF22CE-C6DB-4AF6-B5DD-22E80CD90EA1

P356

P1433

P1476

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

@en

P2093

E M Quigley

http://www.w3.org/2001/XMLSchema#string

G Holtman

http://www.w3.org/2001/XMLSchema#string

G N J Tytgat

http://www.w3.org/2001/XMLSchema#string

I M Modlin

http://www.w3.org/2001/XMLSchema#string

J Tack

http://www.w3.org/2001/XMLSchema#string

P Malfertheiner

http://www.w3.org/2001/XMLSchema#string

R C Heading

http://www.w3.org/2001/XMLSchema#string

R H Hunt

http://www.w3.org/2001/XMLSchema#string

S F Moss

http://www.w3.org/2001/XMLSchema#string

Vevey NERD Consensus Group

http://www.w3.org/2001/XMLSchema#string

P2860

Medical treatments in the short term management of reflux oesophagitis

Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease

Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease

Grading quality of evidence and strength of recommendations

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment

Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease.

Symptom-based outcome measures for dyspepsia and GERD trials: a systematic review.

Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.

Understanding controlled trials. Crossover trials

P304

74-88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000219365

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

80

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232444375

http://www.w3.org/2001/XMLSchema#string

P698

19546560

http://www.w3.org/2001/XMLSchema#string

P921

P932

2790735

http://www.w3.org/2001/XMLSchema#string